AMLX

AMLX Operating Income Growth

17.70%TTM

Period ending:

AMLX TTM Operating Income YoY %%
AMLX TTM Operating Income YoY %508.83%-3516.64%
2022-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

AMLX operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 16 observations from Sep 30, 2022 to Jun 30, 2026.

Amylyx Pharmaceuticals Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
17.7033%
23.2639%
47.4812%
36.8849%
-27.1537%
-155.3713%
-852.2293%
-3,127.0809%
-90.9511%
47.76%
119.2718%
95.8257%
47.0802%
-32.2577%
-143.4948%
-193.9141%

Compare operating income growth

All AMLX financial metrics · AMLX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.